Immunosuppressant compounds, methods and uses related thereto

Details for Australian Patent Application No. 2003218401 (hide)

Owner GPC Biotech AG

Inventors Brandstetter, Tilmann; Nagy, Zoltan

Agent Shelston IP

Pub. Number AU-B-2003218401

PCT Number PCT/US03/09219

PCT Pub. Number WO2003/082197

Priority 60/367,123 22.03.02 US

Filing date 24 March 2003

Wipo publication date 13 October 2003

Acceptance publication date 4 September 2008

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 38/03 (2006.01) Medicinal preparations containing peptides - Peptides having up to 20 amino acids in an undefined or only partially defined sequence

A61P 1/12 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 1/16 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 1/18 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 5/14 (2006.01) Drugs for disorders of the endocrine system

A61P 5/40 (2006.01) Drugs for disorders of the endocrine system

A61P 7/04 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 7/06 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 13/12 (2006.01) Drugs for disorders of the urinary system

A61P 17/02 (2006.01) Drugs for dermatological disorders

A61P 17/06 (2006.01) Drugs for dermatological disorders

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 21/00 (2006.01) Drugs for disorders of the muscular or neuromuscular system

A61P 21/04 (2006.01) Drugs for disorders of the muscular or neuromuscular system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 37/06 (2006.01) Drugs for immunological or allergic disorders

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07K 5/065 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 5/087 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 5/107 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 7/02 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

C07K 7/06 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

Event Publications

31 July 2003 Complete Application Filed

  Priority application(s): 60/367,123 22.03.02 US

20 November 2003 Application Open to Public Inspection

  Published as AU-B-2003218401

4 September 2008 Application Accepted

  Published as AU-B-2003218401

8 January 2009 Standard Patent Sealed

22 October 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003218402-CUSTOMER ACQUISITION IN A LOYALTY SYSTEM

2003218400-FUEL INJECTOR FOR AN INTERNAL COMBUSTION ENGINE